Jiangsu Hengrui Pharmaceuticals Co.,Ltd

1276.HK·HKSE
Compare
49.580+0.060 (+0.12%)today
At close: Oct 21, 4:08 PM HKT · May be delayed up to 15 min · HKD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close49.520
Open49.980
Day range49.44050.850
52-week range43.02080.950
Off day high−2.50%
Off 52-week high−38.75%
Volume4.98M
Avg. volume (3M)4.89M
Market cap329.07B
EPS (TTM)1.30
Forward P/E29.60
P/E ratio (TTM)38.14
Dividend yield0.42% (0.2300)
Beta (5Y)—
Shares outstanding258.20M
Short interest—
Earnings dateAug 20, 2025
Analyst target—
Profit margin—

Against its peers

Compare in full ›
1276.HK 3692.HK 002603.SZ 000661.SZ 600750.SS 000538.SZ
Market cap 329.07B 208.44B 25.56B 28.21B 14.70B 94.21B
P/E (TTM) 38.1 28.0 18.7 — 16.6 18.1
Forward P/E 29.6 25.7 14.0 6.3 15.4 16.3
Price/book 4.5 4.7 2.3 1.2 3.7 2.3
Dividend yield 0.42% 1.41% 5.22% 0.23% 5.83% 2.97%
1-year change −36.55% −1.72% −12.19% −41.68% +8.78% −5.44%
Today +0.12% 0.00% −0.26% −1.43% −2.24% −1.09%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All 1276.HK news ›
MarketScreener·Positive

Jiangsu Hengrui Pharmaceuticals Co.,Ltd : Insider Transactions

Follow insider transactions on Jiangsu Hengrui Pharmaceuticals Co.,Ltd in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Jiangsu Hengrui Pharmaceuticals Co.,Ltd Latest…

From articles in the 4Search news index.

In the news

12mentions in 30 days
12with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.